Neuronetics Stock In The News

STIM Stock  USD 3.40  0.02  0.59%   
Our overall analysis of Neuronetics' news coverage and content from conventional and social sources shows investors' bearish mood towards Neuronetics. The specific impact of Neuronetics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Neuronetics' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Neuronetics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Neuronetics Backtesting and Neuronetics Hype Analysis.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Neuronetics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2025/08/06/3128754/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Investing News at Macroaxis
Canaccord Genuity lowers Neuronetics stock price target on margin concerns
https://www.investing.com/news/analyst-ratings/canaccord-genuity-lowers-neuronetics-stock-price-target-on-margin-concerns-93CH-4173013
 Bullish
seekingalpha News
Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises
https://seekingalpha.com/news/4478851-neuronetics-adjusts-2025-gross-margin-guidance-to-48-percentminus-50-percent-as-greenbrook?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
nasdaq News
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss
https://www.chartmill.com/news/STIM/Chartmill-32324-Neuronetics-Inc-NASDAQSTIM-Reports-Mixed-Q2-2025-Earnings-Revenue-Beat-Overshadowed-by-Wider-Than-Expected-Loss
 Neutral
seekingalpha News
Neuronetics GAAP EPS of -$0.15 misses by $0.07, revenue of $38.11M beats by $1.17M
https://seekingalpha.com/news/4478274-neuronetics-gaap-eps-of-0_15-misses-by-0_07-revenue-of-38_11m-beats-by-1_17m?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
Macroaxis News: globenewswire.com
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
https://www.globenewswire.com/news-release/2025/08/05/3127211/0/en/Neuronetics-Reports-Second-Quarter-2025-Financial-and-Operating-Results.html
 Neutral
Macroaxis News: globenewswire.com
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
https://www.globenewswire.com/news-release/2025/08/04/3126913/0/en/Neuronetics-to-Present-at-the-Canaccord-Genuity-45th-Annual-Growth-Conference.html
 Neutral
Macroaxis News: globenewswire.com
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
https://www.globenewswire.com/news-release/2025/07/30/3124076/0/en/NeuroStar-Announces-New-Publication-in-JAACAP-Open-Highlighting-Treatment-Efficacy-in-Depressed-Adolescents.html
 Neutral
Macroaxis News: globenewswire.com
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call
https://www.globenewswire.com/news-release/2025/07/22/3119413/0/en/Neuronetics-to-Report-Second-Quarter-2025-Financial-and-Operating-Results-and-Host-Conference-Call.html
 Neutral
seekingalpha News
Neuronetics appoints Steven Pfanstiel as chief financial officer
https://seekingalpha.com/news/4467409-neuronetics-appoints-steven-pfanstiel-as-chief-financial-officer?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral

Neuronetics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Neuronetics and other traded companies coverage with news coverage. We help investors stay connected with Neuronetics headlines for the 26th of August to make an informed investment decision based on correlating the impacts of news items on Neuronetics Stock performance. Please note that trading solely based on the Neuronetics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Neuronetics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Neuronetics investors visualize upcoming and past events in order to time the market based on Neuronetics noise-free hype analysis.

Neuronetics Investors Sentiment

The influence of Neuronetics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Neuronetics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Neuronetics' public news can be used to forecast risks associated with an investment in Neuronetics. The trend in average sentiment can be used to explain how an investor holding Neuronetics can time the market purely based on public headlines and social activities around Neuronetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neuronetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neuronetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Neuronetics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Neuronetics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neuronetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neuronetics' short interest history, or implied volatility extrapolated from Neuronetics options trading.
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out Neuronetics Backtesting and Neuronetics Hype Analysis.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
2.278
Quarterly Revenue Growth
1.317
Return On Assets
(0.20)
Return On Equity
(1.91)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.